Laura Novello
Pediatric Endocrinology · Shrewsbury, NJNPI 1780976332
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $545 and has fallen 63.9% since, to $197 in 2025.
Across 91 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$232
- Novo Nordisk$231
- Abbott$190
- Tandem Diabetes Care, Inc.$163
- Sanofi-aventis U.S. LLC$155
- Pfizer$126
- plus $682 from 17 others
What the payments were for
- Food & beverage$1,76599%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 5 | $232 |
| Novo Nordisk | 20 | $231 |
| Abbott | 5 | $190 |
| Tandem Diabetes Care, Inc. | 5 | $163 |
| Sanofi-aventis U.S. LLC | 3 | $155 |
| Pfizer | 9 | $126 |
| Xeris Pharmaceuticals, Inc. | 8 | $121 |
| Insulet Corporation | 5 | $77 |
| Endo Pharmaceuticals Inc. | 5 | $69 |
| Biomarin Pharmaceutical Inc. | 1 | $63 |
| AbbVie | 4 | $51 |
| Dexcom, Inc. | 3 | $50 |
| Ascendis Pharma Endocrinology Inc | 3 | $45 |
| Lilly USA, LLC | 3 | $39 |
| Arbor Pharmaceuticals, Inc. | 2 | $31 |
| Ferring Pharmaceuticals Inc. | 2 | $25 |
| IBSA Pharma Inc. | 2 | $24 |
| Eton Pharmaceuticals, Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| AstraZeneca | 1 | $16 |
| Tolmar, Inc. | 1 | $14 |
| Amphastar Pharmaceuticals, Inc. | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TZIELD$125
- MINIMED 780G$109
- FreeStyle Libre 2$103
How this compares
$1,779 in reported general payments places this provider in the 65th percentile of 59 pediatric endocrinology providers in New Jersey.
Other pediatric endocrinology in Shrewsbury
- Frank BarrowsShrewsbury$3K
- Lawrence SilvermanMorristown$492K
- Ahmed KhattabNew Brunswick$70K
- Ian MarshallNew Brunswick$51K
- Dennis BrennerWest Orange$39K
- Eric HuangBasking Ridge$23K
- Irene MamkinWest Orange$13K
- Elizabeth BurtmanTenafly$10K
- Javier AisenbergHackensack$10K
- Hope-Elizabeth ClennonNewark$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.